[-] Show simple item record

dc.contributor.authorMeriwether, Rebecca A.eng
dc.date.issued2001-12eng
dc.description.abstractTamoxifen prevents breast cancer in women older than 60 years and in younger women with equally high risk because of breast disease and reproductive and family history, but there is no current evidence for or against long-term survival or overall health benefits.(Grade of recommendation A: randomized controlled trials [RCTs]) a 49% reduction in 5-year incidence of invasive and noninvasive breast cancer but increased risk for endometrial cancer, pulmonary emboli, deep vein thrombosis, and cataracts. The long-term benefits and overall health effects of tamoxifen for primary prevention of breast cancer remain unclear; the ongoing International Breast Cancer Intervention Study trial is designed to address this question.eng
dc.identifier.urihttp://hdl.handle.net/10355/2795eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2001 (MU)eng
dc.relation.ispartofcollectionUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subjectbreast diseaseeng
dc.subjectdisease preventioneng
dc.subjectrisk factoreng
dc.subject.lcshTamoxifeneng
dc.subject.lcshCancer -- Treatmenteng
dc.subject.lcshBreast -- Cancereng
dc.subject.lcshBreast -- Cancer -- Risk factorseng
dc.titleDoes tamoxifen prevent breast cancer?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record